FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Warnings Sought on Isotretinoin Sexual Effects

Three medical school professors ask FDA to add warning language about sexual side effects to labeling for all drug products containing isotretinoin.

Federal Register

Bone Conduction Hearing System into Class 2

Federal Register notice: FDA classifies the active implantable bone conduction hearing system into Class 2 (special controls).

Federal Register

Class 2 for Humidified Oxygen Delivery Devices

Federal Register notice: FDA classifies high-flow humidified oxygen delivery devices into Class 2 (special controls).

Federal Register

Rebinyn Regulatory Review Period Determined

Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Novo Nordisks Rebinyn (coagulation fact...

Medical Devices

Align Technology Gains Clearance for Revised Invisalign

FDA clears an Align Technology 510(k) for the Invisalign treatment with mandibular advancement, a clear aligner solution for Class 2 teeth alignment c...

Research Mulls Approach to Qualify Patient-reported Measures

New research supported by CDRHs Division of Biostatistics outlines an approach that could lead to more patient-reported outcome measures to be include...

Federal Register

Circulatory System Device Panel to Meet 12/4-5

Federal Register notice: FDA announces a12/4-5 Circulatory System Devices Panel of the Medical Devices Advisory Committee.

Human Drugs

Abbott/AbbVie Pay $25 Million in Off-Label Case

Abbott Laboratories and its spin-off AbbVie agree to pay $25 million to resolve allegations that they used kickbacks and off-label marketing and promo...

Human Drugs

Dangerous, Unethical Tests at Minn. Medical Center: Public Citizen

FDA inspects a Minnesota medical center and finds violations that subjected unwitting patients to dangerous and unethical human testing, according to ...

Human Drugs

FDA Approves Jazz Pharmas Xyrem for Pediatric Cataplexy

FDA approves a Jazz Pharmaceuticals supplemental NDA to revise labeling for Xyrem (sodium oxybate) oral solution to include an indication to treat cat...